نتائج البحث 401-410 من 13675 لعملية البحث عن Hyperuricaemia / gout risk
... risk (International Prognostic Index [IPI] 3 to 5), a-BCL. The primary objective of Part 2 of this study is to further evaluate the safety and tolerability ...
... risk factors for developing hematological toxicity including t-MN in radiotheranostic treated solid tumor patients. A Study of Immune Cell Abnormalities ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...
... risk of recurrence based on histological interpretation of the ILND specimen. Patients at high risk of relapse are eligible for InPACT-pelvis, where they ...
Despite not needing therapy, these patients have significant immune dysfunction. This may lead to an increased risk of serious infections requiring ...
Coronary artery disease. In: Color Atlas and Synopsis of Heart Failure. McGraw Hill; 2019. Wilson PWF. Overview of the possible risk factors for cardiovascular ...
The purpose of this study is to verify that high Premature Ventricular Complex (PVC) burden is associated with increased risk of stroke and/or Transient ...
The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.